ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that its wholly-owned subsidiary, Naturevan Nutrition Ltd. ("Naturevan"), has shipped its first batch of vitamin products to Amazon U.S.A.
Management foresees Naturevan exceeding its exceptions as the vitamin market in North America emerges as a leading market for dietary supplements in the North American region. The American vitamin market, valued at $151.0 billion in 2021, is expected to increase at a compound annual growth of 8.9% from 2022 to 2030. According to the latest data from the U.S Dietary Supplements Market, there is an increased consumer awareness towards health and wellness, which is expected to be the driving factor for the increase of dietary supplements over time. Due to demanding work and lifestyle schedules, there is a reported increase in dependence on supplements to fulfill the nutrient requirement for a healthy lifestyle. Furthermore, vitamins dominated the dietary supplement market and accounted for more than 30.8% of the revenue share in 2021. (Source: https://www.grandviewresearch.com/industry-analysis/dietary-supplements-market)
"The Company is thrilled to achieve this significant milestone. With plans to expand to Amazon Canada shortly, this new vertical truly diversifies ScreenPro's product offerings and exposes the Company to new revenue and profit avenues. With the U.S.A vitamin market gaining popularity for health and wellness, management believes entering the vitamin market and selling on a major eCommerce platform such as Amazon will give great returns. We are close to execution and will share more developments soon," said Andrew Ryu, Chief Executive Officer and Chairman of the Company.
About Naturevan Nutrition
Naturevan is a provider of natural health supplements and products proudly made in Canada and distributed online and through agents across Canada. Canada's natural health supplement market is globally recognized as having first-rate standards and guidelines, so consumers receive the highest standard of nutrition. To learn more about Naturevan and its products, visit www.naturevan.ca.
About ScreenPro
ScreenPro is a medical technology company that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario, and Quebec allows ScreenPro to be a full-service nationwide provider of COVID testing and breast cancer screening solutions across Canada. In addition, ScreenPro's subsidiary, Concierge Medical, is a group of board-certified physicians who provide private, discreet, and personalized healthcare to Canadians. ScreenPro prides itself in having its medical doctors and nursing professionals with on-the-ground support staff and transportation, with access to high-quality PPEs to ensure that clients are protected in all aspects of their testing needs. ScreenPro also newly introduced Naturevan Nutrition Ltd. to its portfolio, providing vitamins and supplements that are proudly made in Canada and distributed for sale online.
For additional information on ScreenPro and other corporate information, please visit the Company's website at www.screenprosecurity.com.
For more information about the Company, please refer to the Company's profile on SEDAR at www.sedar.com.
Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
For further information:
Investor Relations & Communications
Priya Monique Atwal, Director of Communications
Tel: (416) 901-5611 x 204
Email: priya@screenprosecurity.com
Andrew Ryu, Interim Chief Executive Officer and Chairman
Tel: 416-901-5611 x 201
Email: aryu@datametrex.com
Forward Looking Statements:
Certain statements contained in this news release may constitute forward‐looking information, including statements relating to the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.
###
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/140441